KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Capital Expenditures: 2015-2025

Historic Capital Expenditures for Medpace Holdings (MEDP) over the last 10 years, with Sep 2025 value amounting to $10.7 million.

  • Medpace Holdings' Capital Expenditures rose 1.67% to $10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.5 million, marking a year-over-year decrease of 11.39%. This contributed to the annual value of $36.5 million for FY2024, which is 0.27% down from last year.
  • According to the latest figures from Q3 2025, Medpace Holdings' Capital Expenditures is $10.7 million, which was up 75.25% from $6.1 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Capital Expenditures ranged from a high of $12.9 million in Q2 2024 and a low of $5.5 million during Q1 2024.
  • Over the past 3 years, Medpace Holdings' median Capital Expenditures value was $9.5 million (recorded in 2023), while the average stood at $9.1 million.
  • Its Capital Expenditures has fluctuated over the past 5 years, first surged by 86.42% in 2022, then tumbled by 52.51% in 2025.
  • Medpace Holdings' Capital Expenditures (Quarterly) stood at $9.1 million in 2021, then climbed by 1.39% to $9.2 million in 2022, then grew by 8.04% to $10.0 million in 2023, then declined by 23.46% to $7.6 million in 2024, then increased by 1.67% to $10.7 million in 2025.
  • Its last three reported values are $10.7 million in Q3 2025, $6.1 million for Q2 2025, and $10.0 million during Q1 2025.